BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8923716)

  • 1. Virulence, immunogenicity and reactivation of seven bovine herpesvirus 1.1 strains: clinical and virological aspects.
    Kaashoek MJ; Straver PH; Van Rooij EM; Quak J; Van Oirschot JT
    Vet Rec; 1996 Oct; 139(17):416-21. PubMed ID: 8923716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
    König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
    Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
    Ellis J; Waldner C; Rhodes C; Ricketts V
    J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine.
    Kaashoek MJ; Moerman A; Madić J; Rijsewijk FA; Quak J; Gielkens AL; van Oirschot JT
    Vaccine; 1994 Apr; 12(5):439-44. PubMed ID: 8023552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypervaccination with bovine herpesvirus type 1 gE-deleted marker vaccines on the serological response and virological status of calves challenged with wild-type virus.
    Toussaint JF; Rziha HJ; Bauer B; Letellier C; Kerkhofs P
    Vet Rec; 2004 Oct; 155(18):553-8. PubMed ID: 15559987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
    Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social isolation may influence responsiveness to infection with bovine herpesvirus 1 in veal calves.
    van Reenen CG; Mars MH; Leushuis IE; Rijsewijk FA; van Oirschot JT; Blokhuis HJ
    Vet Microbiol; 2000 Jul; 75(2):135-43. PubMed ID: 10889404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
    Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
    J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
    Wei H; He J; Paulsen DB; Chowdhury SI
    Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the immune response and virological protection of calves against bovine herpesvirus type 1 with an inactivated gE-deleted vaccine.
    Kerkhofs P; Renjifo X; Toussaint JF; Letellier C; Vanopdenbosch E; Wellemans G
    Vet Rec; 2003 May; 152(22):681-6. PubMed ID: 12803395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.
    Jericho KW; Babiuk LA
    Can J Comp Med; 1983 Apr; 47(2):133-9. PubMed ID: 6309347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempted reactivation of latent bovine herpesvirus 1 infection in calves by infection with ruminant pestiviruses.
    Edwards S; Roeder PL
    Vet Microbiol; 1983 Nov; 8(6):563-9. PubMed ID: 6318422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA.
    van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Rijsewijk FA
    Vet Microbiol; 1999 Mar; 65(2):103-13. PubMed ID: 10078594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
    Gao Y; Leary TP; Eskra L; Splitter GA
    Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.